Skip to main content
House Bill 1014

House Bill 1014

ARCHIVE (2013)

Latest Information


Income tax credit for specialty drugs. Provides a refundable individual income tax credit to the extent that a taxpayer's copayment or coinsurance amount in a particular year for specialty drugs exceeds 8% of the taxpayer's federal adjusted gross income for that year. Defines "specialty drug" as a drug that meets the following conditions: (1) The amount of coinsurance or copayments paid for the drug is more than $600 per month. (2) The drug is included in a specialty pricing group or tier. (3) The drug satisfies other requirements concerning use, handling, and patient management. (The introduced version of this bill was prepared by the health finance commission.)
Current Status:
In Committee - first House
Latest Printing (PDF)